A pregnant woman is attending her second prenatal visit. Prenatal lab work indicates she is not immune to the rubella virus. What is the most appropriate nursing intervention?

Choice A rationale Rubella infection during pregnancy, especially in the first trimester, carries a significant risk of Congenital Rubella Syndrome (CRS), leading to severe fetal anomalies (e.g., cataracts, deafness, cardiac defects). The rubella vaccine is a live attenuated virus, and its administration during pregnancy is contraindicated due to the theoretical risk of fetal infection from the vaccine virus. Therefore, vaccination must be postponed until the immediate postpartum period, ensuring the woman is not pregnant and instructing her to avoid conception for 4 weeks post-vaccination. Choice B rationale The rubella vaccine is a live attenuated virus and is contraindicated during pregnancy because of the theoretical risk of teratogenicity from vertical transmission of the vaccine virus to the fetus. The risk of Congenital Rubella Syndrome (CRS) from the vaccine is low but serious enough to warrant contraindication. Immediate administration is unsafe and medically inappropriate while the patient is pregnant. Choice C rationale While the rubella vaccine is postponed, delaying all immunizations until one month postpartum is an overgeneralized and unnecessary restriction. Other non-live vaccines, such as the Tetanus, Diphtheria, and acellular Pertussis (Tdap) vaccine, are recommended during the third trimester (27–36 weeks gestation) to provide passive immunity to the newborn against pertussis (whooping cough), demonstrating that not all immunizations are universally held. Choice D rationale The decision to withhold the rubella vaccine during pregnancy is a medical contraindication based on safety principles related to live vaccines and the developing fetus, not a discretionary choice left to the patient prenatally. The standard of care mandates that the vaccine be deferred until the postpartum period to prevent the theoretical risk of vaccine-induced fetal harm, making pre-delivery administration and decision-making for a live vaccine medically inappropriate.